Eramel, Christy Jean A.
HRN: 26-43-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/13/2026
02/20/2026
IV
500mg
Q8H
NKA
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines